
Join to View Full Profile
1205 N High StMillville, NJ 08332
Dr. Wisda is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Catherine Wisda is an ophthalmologist based in Millville, NJ, with education from Rutgers New Jersey Medical School, graduating in 1986, followed by a residency in ophthalmology at Newark Eye - Ear Infirmary from 1987 to 1990. She has worked at Wisda Eye Center PC since 2011. Dr. Wisda has published a case report on vision loss following denileukin diftitox treatment in the journal Leukemia & Lymphoma, which has been cited 11 times. She holds certifications in CMS Meaningful Use Stages 1 and 2 and is a Fellow of the American Academy of Ophthalmology.
Education & Training
Newark Eye - Ear InfirmaryResidency, Ophthalmology, 1987 - 1990
Rutgers New Jersey Medical SchoolClass of 1986
Certifications & Licensure
NJ State Medical License 1987 - 2027
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification ChartMaker Medical Suite, STI Computer Services, Inc., 2014-2017
- CMS Meaningful Use Stage 2 Certification ChartMaker Medical Suite, STI Computer Services, Inc., 2014-2017
- Fellow (FAAO) American Academy of Ophthalmology
Publications & Presentations
PubMed
- 11 citationsVision loss following denileukin diftitox treatment: A case report of possible posterior ischemic optic neuropathyMeyeon Park, Grant T. Liu, Jody R. Piltz-Seymour, Catherine L. Wisda, Alain H. Rook
Leukemia & Lymphoma. 2007-01-01
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









